Cargando…

Aldosterone receptor antagonists: current perspectives and therapies

Aldosterone is a downstream effector of angiotensin II in the renin–angiotensin–aldosterone system and binds to the mineralocorticoid receptor. The classical view of aldosterone primarily acting at the level of the kidneys to regulate plasma potassium and intravascular volume status is being supplem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guichard, Jason L, Clark, Donald, Calhoun, David A, Ahmed, Mustafa I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699348/ https://www.ncbi.nlm.nih.gov/pubmed/23836977 http://dx.doi.org/10.2147/VHRM.S33759

Ejemplares similares

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
por: Nappi, Jean M, et al.
Publicado: (2011)

Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review
por: Mai, Xurong, et al.
Publicado: (2022)

Aldosteronism and Resistant Hypertension
por: Acelajado, Maria Czarina, et al.
Publicado: (2011)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2021)

Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists
por: Yoshida, Yuichi, et al.
Publicado: (2021)

SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening
por: Tezuka, Yuta, et al.
Publicado: (2020)

Suppression of Aldosterone Synthesis and Secretion by Ca(2+) Channel Antagonists
por: Ikeda, Keiichi, et al.
Publicado: (2012)

CRTH2 antagonists in asthma: current perspectives
por: Singh, Dave, et al.
Publicado: (2017)

PSUN68 Finerenone for Primary Aldosteronism: A Novel Mineralocorticoid Receptor Antagonist
por: Aurora, John, et al.
Publicado: (2022)

Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
por: Enevoldsen, Frederik C., et al.
Publicado: (2020)

Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis
por: Jansen, Pieter M., et al.
Publicado: (2011)

Rates of hospitalization associated with the use of aldosterone receptor antagonists in patients with pulmonary arterial hypertension
por: Corkish, Morgan E., et al.
Publicado: (2019)

A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
por: Epstein, Murray
Publicado: (2022)

Treatment of heart failure with ACE inhibitors and beta-blockers: What is next? Aldosterone receptor antagonists?
por: van der Horst, Iwan C. C., et al.
Publicado: (2007)

Renin-Angiotensin-Aldosterone System Inhibition and Mineralocorticoid Receptor Antagonists: The Overriding Importance of Enablers and Dampers
por: Epstein, Murray
Publicado: (2021)

Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism
por: Lin, Yu-Fang, et al.
Publicado: (2020)

Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective
por: Chałupnik, Paulina, et al.
Publicado: (2023)

Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
por: Muñoz-Durango, N., et al.
Publicado: (2015)

Aldosterone Antagonists Reduce the Risk of Cardiovascular Mortality in Dialysis Patients: A Meta-Analysis
por: Li, Yan, et al.
Publicado: (2019)

Aldosterone and Its Blockade: A Cardiovascular and Renal Perspective
por: Lahera, V., et al.
Publicado: (2006)

Use of Aldosterone Antagonist to Treat Diarrhea and Hypokalemia of Ogilvie's Syndrome
por: Ram, Pradhum, et al.
Publicado: (2016)

Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?
por: Escobar, Carlos, et al.
Publicado: (2019)

NK-1 Receptor Antagonists and Pruritus: Review of Current Literature
por: Pojawa-Gołąb, Marcelina, et al.
Publicado: (2019)

Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
por: Dinh, Quynh N, et al.
Publicado: (2012)

Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations
por: Lim, Jung Soo, et al.
Publicado: (2021)

Genetics of Primary Aldosteronism
por: Scholl, Ute I.
Publicado: (2022)

RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes
por: Benter, Ibrahim F., et al.
Publicado: (2013)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives
por: Vizzardi, Enrico, et al.
Publicado: (2014)

Aldosterone synthase inhibitors in hypertension: current status and future possibilities
por: Hargovan, Milan, et al.
Publicado: (2014)

A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy
por: Fujihara, Clarice K., et al.
Publicado: (2017)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Primary aldosteronism: A Japanese perspective
por: Satoh, Fumitoshi, et al.
Publicado: (2011)

Illness perspectives in patients with primary aldosteronism
por: Ragnarsson, Oskar, et al.
Publicado: (2022)

Retinoic acid receptor antagonists for male contraception: current status(†)
por: Noman, Md Abdullah Al, et al.
Publicado: (2020)

Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
por: Lin, Yu-Hsuan, et al.
Publicado: (2021)

Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats
por: Banki, Nora F., et al.
Publicado: (2012)

Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan
por: Mayyas, Fadia, et al.
Publicado: (2017)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
por: Cannavo, Alessandro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_27k5a8pn5hg8vtoettjd30c4ii